Lupus Nephritis: Role of Environmental and Occupational Exposures
NCT00342329 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2017-07-02
Summary
The purpose of this study is to examine hormonal and environmental risk factors (and possible gene-environmental interactions) involved in the etiology of lupus nephritis. Our study will focus on exposures to occupational and environmental agents that have been linked to the development of systemic lupus erythematosus (SLE) or renal disease (e.g., silica dust, smoking). We will also assess potential gene environment interactions. We will examine these exposures in 100 patients with renal biopsy with documented proliferative or membraneous nephritis. We will compare exposures in the lupus nephritis patients to lupus patients who do not have nephritis and to normal controls who have participated in the Carolina Lupus Study. One hundred lupus nephritis patients (age 18 years or older, of both genders and all races) will be identified through the Glomerular Disease Collaborative Network (GDCN) Nephropathology database and participating nephrologists at the Medical University of South Carolina, Duke University Medical Center and the East Carolina Medical School.
Conditions
Sponsors & Collaborators
-
National Institute of Environmental Health Sciences (NIEHS)
lead NIH
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-04-16
- Completion
- 2007-03-07
Countries
- United States
Study Locations
More Related Trials
-
Identifying New Therapeutic Targets for Lupus Treatment
NCT03921398 ·Status: COMPLETED
-
SSerum/Urinary Monocyte Chemoattractant Protein-1 Level as a Marker for Lupus Nephritis
NCT03164720 ·Status: UNKNOWN
-
Renal Survival in Patients with Lupus Nephritis
NCT06588192 ·Status: NOT_YET_RECRUITING
-
Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients
NCT01470183 ·Status: COMPLETED
-
T Regulatory Cells IN LUPUS NEPHRITIS
NCT06428539 ·Status: NOT_YET_RECRUITING
-
Prognostic Factors for Treatment Responses in Patients With Active Lupus Nephritis at Sohag University Hospital
NCT04756492 ·Status: UNKNOWN
-
Occupational and Environmental Causes of Autoimmune Diseases
NCT07000903 ·Status: COMPLETED ·Phase: NA
-
Gut Microbiota Dysbiosis in Lupus Nephritis
NCT06231303 ·Status: NOT_YET_RECRUITING
-
AntiDFS70 Lupus Nephritis
NCT06119763 ·Status: RECRUITING
-
Epigenetics in Lupus Nephritis
NCT04648059 ·Status: UNKNOWN
-
Drug Therapy in Lupus Nephropathy
NCT00001212 ·Status: COMPLETED ·Phase: PHASE2
-
Prediction of Outcome of Lupus Nephritis
NCT02403115 ·Status: UNKNOWN
-
A Study of Clinical Characteristics ,Risk Factors and Outcome of Lupus Nephritis Among Children With Systemic Lupus Erthromatousus in Sohag Univeristy Hospital
NCT06491602 ·Status: RECRUITING
-
Anti-ficolin-3 Antibodies in Lupus Nephritis
NCT03842787 ·Status: COMPLETED
-
PRediction Of Flares In Lupus With autoantibodiEs and Chemokines
NCT04951427 ·Status: UNKNOWN
-
The Expression Profile of New Complement Components in Childhood Lupus Nephritis
NCT05082363 ·Status: UNKNOWN
-
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
NCT01273389 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Lupus Nephritis.
NCT03610516 ·Status: COMPLETED ·Phase: PHASE2
-
Functional MRI in Lupus Nephritis
NCT01731054 ·Status: COMPLETED
-
Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics Analysis
NCT06167174 ·Status: RECRUITING
-
Anti-ficolin-2 Autoantibodies in Lupus Nephritis
NCT03063281 ·Status: COMPLETED
-
Serologically Active, Clinically Stable Systemic Lupus Erythematosus
NCT00000421 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy and Safety of Telitacicept and Belimumab in Active Lupus Nephritis in the Real World: a Prospective Cohort Study
NCT05588830 ·Status: UNKNOWN
-
Study of Systemic Lupus Erythematosus
NCT00001372 ·Status: RECRUITING
-
Etanercept for the Treatment of Lupus Nephritis
NCT00447265 ·Status: TERMINATED ·Phase: PHASE2